Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2021 Jun 25;5(7):e612.
doi: 10.1097/HS9.0000000000000612. eCollection 2021 Jul.

EPICOVIDEHA: A Ready to Use Platform for Epidemiological Studies in Hematological Patients With COVID-19

Jon Salmanton-García  1   2 , Alessandro Busca  3 , Oliver A Cornely  1   2   4   5   6 , Paolo Corradini  7 , Martin Hoenigl  8   9   10 , Nikolai Klimko  11 , Francesco Marchesi  12 , Antonio Pagliuca  13 , Francesco Passamonti  14 , Philipp Koehler  1   2 , Livio Pagano  15   16
Affiliations
Editorial

EPICOVIDEHA: A Ready to Use Platform for Epidemiological Studies in Hematological Patients With COVID-19

Jon Salmanton-García et al. Hemasphere. .
No abstract available

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Countries contributing to EPICOVIDEHA, as of April 2021. (A), Countries colored in the map are: Argentina, Austria, Azerbaijan, Belarus, Belgium, Brazil, Canada, Croatia, Czech Republic, Denmark, Egypt, France, Germany, Greece, Hong Kong SAR, Hungary, Italy, The Netherlands, Oman, Pakistan, Portugal, Qatar, Russia, Serbia, Spain, Sweden, Switzerland, Turkey, and The United Kingdom. Name of institutions is listed in Supplemental Digital Table 1, http://links.lww.com/HS/A171. (B), European countries contributing to EPICOVIDEHA, as of April 2021. Countries colored in the map are: Austria, Azerbaijan, Belarus, Belgium, Croatia, Czech Republic, Denmark, France, Germany, Greece, Hungary, Italy, The Netherlands, Portugal, Russia, Serbia, Spain, Sweden, Switzerland, Turkey, and The United Kingdom. Name of institutions is listed in Supplemental Digital Table 1, http://links.lww.com/HS/A171.
See this image and copyright information in PMC

References

    1. Trecarichi EM, Pagano L, Candoni A, et al. . Current epidemiology and antimicrobial resistance data for bacterial bloodstream infections in patients with hematologic malignancies: an Italian multicentre prospective survey. Clin Microbiol Infect.2015; 21:337–343 - PubMed
    1. Cattaneo C, Di Blasi R, Skert C, et al. . Bloodstream infections in haematological cancer patients colonized by multidrug-resistant bacteria. Ann Hematol.2018; 97:1717–1726 - PubMed
    1. Koehler P, Hamprecht A, Bader O, et al. . Epidemiology of invasive aspergillosis and azole resistance in patients with acute leukaemia: the SEPIA Study. Int J Antimicrob Agents.2017; 49:218–223 - PubMed
    1. Pagano L, Cornely OA, Busca A, et al. . Combined antifungal approach for the treatment of invasive mucormycosis in patients with hematologic diseases: a report from the SEIFEM and FUNGISCOPE registries. Haematologica.2013; 98:e127–e130 - PMC - PubMed
    1. Gabutti G, De Motoli F, Sandri F, et al. . Viral respiratory infections in hematological patients. Infect Dis Ther.2020; 9:495–510 - PMC - PubMed

Publication types